JPY 147.0
(10.53%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -255.5 Million JPY | 89.55% |
2022 | -2.44 Billion JPY | -29.09% |
2021 | -1.89 Billion JPY | 5.86% |
2020 | -2.01 Billion JPY | 35.0% |
2019 | -3.09 Billion JPY | -21.2% |
2018 | -2.55 Billion JPY | -36.88% |
2017 | -1.86 Billion JPY | -34.01% |
2016 | -1.39 Billion JPY | 43.38% |
2015 | -2.45 Billion JPY | -23.28% |
2014 | -1.99 Billion JPY | -30.79% |
2013 | -1.52 Billion JPY | -55.92% |
2012 | -978.33 Million JPY | -417.01% |
2011 | 308.61 Million JPY | 157.8% |
2010 | -533.95 Million JPY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -787.41 Million JPY | -277.17% |
2023 Q3 | -560.94 Million JPY | -279.9% |
2023 FY | -255.5 Million JPY | 89.55% |
2023 Q1 | 8.64 Million JPY | 102.38% |
2023 Q2 | -147.65 Million JPY | -1807.8% |
2023 Q4 | 444.44 Million JPY | 179.23% |
2022 FY | -2.44 Billion JPY | -29.09% |
2022 Q4 | -363.28 Million JPY | 78.65% |
2022 Q2 | 143.48 Million JPY | 127.37% |
2022 Q1 | -524.21 Million JPY | -398.59% |
2022 Q3 | -1.7 Billion JPY | -1286.17% |
2021 Q2 | -445.07 Million JPY | 44.16% |
2021 FY | -1.89 Billion JPY | 5.86% |
2021 Q4 | 175.56 Million JPY | 121.2% |
2021 Q3 | -828.14 Million JPY | -86.07% |
2021 Q1 | -797.09 Million JPY | -78.52% |
2020 FY | -2.01 Billion JPY | 35.0% |
2020 Q1 | -408.53 Million JPY | 57.33% |
2020 Q2 | -679.39 Million JPY | -66.3% |
2020 Q3 | -478.17 Million JPY | 29.62% |
2020 Q4 | -446.51 Million JPY | 6.62% |
2019 Q3 | -662.82 Million JPY | -4.01% |
2019 Q4 | -957.54 Million JPY | -44.46% |
2019 FY | -3.09 Billion JPY | -21.2% |
2019 Q1 | -838.5 Million JPY | -27.33% |
2019 Q2 | -637.29 Million JPY | 24.0% |
2018 Q3 | -665.68 Million JPY | -10.08% |
2018 FY | -2.55 Billion JPY | -36.88% |
2018 Q1 | -625.59 Million JPY | -7.06% |
2018 Q4 | -658.54 Million JPY | 1.07% |
2018 Q2 | -604.73 Million JPY | 3.34% |
2017 Q2 | -421.61 Million JPY | -18.76% |
2017 Q1 | -355 Million JPY | -174.45% |
2017 FY | -1.86 Billion JPY | -34.01% |
2017 Q4 | -584.36 Million JPY | -15.66% |
2017 Q3 | -505.22 Million JPY | -19.83% |
2016 FY | -1.39 Billion JPY | 43.38% |
2016 Q4 | -129.35 Million JPY | 61.76% |
2016 Q3 | -338.22 Million JPY | 10.07% |
2016 Q2 | -376.07 Million JPY | 31.49% |
2016 Q1 | -548.91 Million JPY | -2.68% |
2015 FY | -2.45 Billion JPY | -23.28% |
2015 Q1 | -452.76 Million JPY | -11.13% |
2015 Q3 | -993.87 Million JPY | -107.89% |
2015 Q2 | -478.07 Million JPY | -5.59% |
2015 Q4 | -534.61 Million JPY | 46.21% |
2014 Q3 | -439.08 Million JPY | 14.52% |
2014 FY | -1.99 Billion JPY | -30.79% |
2014 Q1 | -634.77 Million JPY | -35.99% |
2014 Q2 | -513.7 Million JPY | 19.07% |
2014 Q4 | -407.4 Million JPY | 7.22% |
2013 Q3 | -356.68 Million JPY | 1.18% |
2013 FY | -1.52 Billion JPY | -55.92% |
2013 Q1 | -340.95 Million JPY | -21.32% |
2013 Q2 | -360.95 Million JPY | -5.86% |
2013 Q4 | -466.77 Million JPY | -30.87% |
2012 Q4 | -281.04 Million JPY | -17.59% |
2012 Q2 | -226.15 Million JPY | 2.57% |
2012 Q1 | -232.12 Million JPY | -150.6% |
2012 FY | -978.33 Million JPY | -417.01% |
2012 Q3 | -239.01 Million JPY | -5.69% |
2011 Q2 | -195.75 Million JPY | -195.81% |
2011 Q4 | 458.74 Million JPY | 389.06% |
2011 Q1 | 204.32 Million JPY | 0.0% |
2011 FY | 308.61 Million JPY | 157.8% |
2011 Q3 | -158.7 Million JPY | 18.93% |
2010 FY | -533.95 Million JPY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
DVx Inc. | 172.91 Million JPY | 247.765% |
Seikagaku Corporation | 2.18 Billion JPY | 111.688% |
Eiken Chemical Co., Ltd. | 2.63 Billion JPY | 109.7% |
Create Medic Co., Ltd. | 154.02 Million JPY | 265.889% |
PHC Holdings Corporation | -12.89 Billion JPY | 98.018% |
Techno Medica Co., Ltd. | 1.34 Billion JPY | 118.953% |
Rion Co., Ltd. | 2.65 Billion JPY | 109.633% |
Nihon Kohden Corporation | 17.02 Billion JPY | 101.501% |
Fukuda Denshi Co., Ltd. | 18.69 Billion JPY | 101.367% |
Japan Lifeline Co., Ltd. | 7.51 Billion JPY | 103.4% |
Japan Medical Dynamic Marketing, INC. | 1.27 Billion JPY | 120.092% |
CYBERDYNE Inc. | -1.47 Billion JPY | 82.689% |